☆Rosalind Advisors, Inc.
Quality Q
0.483
AUM ($M)
266
Positions
29
Turnover
0.17
Top-10 wt
75%
Herfindahl
0.075
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 35 positions · portfolio value $266M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆DCTH funds › | DELCATH SYSTEMS, INC. | HOLD | — | 15.6% | +3.1% | 41.6 | 3,300,389 | +0 | 5 | — |
| ☆FENC funds › | FENNEC PHARMACEUTICALS INC | ADD | — | 12.9% | +5.5% | 34.3 | 3,188,001 | +279,800 | 5 | — |
| ☆XERS funds › | XERIS BIOPHARMA HOLDINGS INC | TRIM | — | 8.7% | +1.0% | 23.0 | 2,908,981 | -322,719 | 5 | — |
| ☆SVRA funds › | SAVARA INC | TRIM | — | 7.4% | +0.2% | 19.6 | 3,178,121 | -25,600 | 5 | — |
| ☆VSTM funds › | VERASTEM INC | ADD | — | 5.7% | +1.1% | 15.2 | 3,986,509 | +1,848,034 | 5 | — |
| ☆XFOR funds › | X4 PHARMACEUTICALS INC | HOLD | — | 5.6% | +0.2% | 15.0 | 3,214,766 | +0 | 4 | — |
| ☆EYPT funds › | EYEPOINT PHARMACEUTICALS INC | TRIM | — | 5.3% | -0.2% | 14.1 | 988,230 | -48,507 | 4 | — |
| ☆HELP funds › | CYBIN INC | ADD | — | 4.9% | +1.8% | 12.9 | 1,956,814 | +425,000 | 5 | — |
| ☆VOR funds › | VOR BIOPHARMA INC | TRIM | — | 4.5% | -0.6% | 11.9 | 648,600 | -51,400 | 2 | — |
| ☆PCVX funds › | VAXCYTE INC | TRIM | — | 4.4% | -2.5% | 11.6 | 200,000 | -90,000 | 2 | — |
| ☆MDWD funds › | MEDIWOUND LTD | HOLD | — | 4.1% | -0.8% | 11.0 | 749,054 | +0 | 5 | — |
| ☆CLDX funds › | CELLDEX THERAPEUTICS INC | TRIM | — | 2.8% | -1.5% | 7.4 | 200,000 | -130,000 | 2 | — |
| ☆BCRX funds › | BIOCRYST PHARMACEUTICALS INC | TRIM | — | 2.7% | -0.9% | 7.2 | 721,504 | -201,553 | 2 | — |
| ☆PROF funds › | PROFOUND MEDICAL CORP | HOLD | — | 2.1% | -0.1% | 5.5 | 828,118 | +0 | 5 | — |
| ☆TLPH funds › | TALPHERA INC | ADD | — | 2.0% | +1.0% | 5.3 | 5,169,501 | +1,815,585 | 5 | — |
| ☆AVIR funds › | ATEA PHARMACEUTICALS INC | TRIM | — | 1.9% | -0.7% | 5.0 | 1,070,550 | -101,305 | 2 | — |
| ☆MYO funds › | MYOMO INC | TRIM | — | 1.4% | +0.4% | 3.8 | 3,637,886 | -209,386 | 5 | — |
| ☆OVID funds › | OVID THERAPEUTICS INC | HOLD | — | 1.1% | +0.1% | 3.0 | 1,107,994 | +0 | 2 | — |
| ☆NRXS funds › | NEURAXIS INC | ADD | — | 1.1% | +0.4% | 3.0 | 508,055 | +221,917 | 3 | — |
| ☆ABVX funds › | ABIVAX SA | NEW | — | 1.0% | +1.0% | 2.8 | 20,869 | +20,869 | 1 | — |
| ☆NSPR funds › | INSPIREMD INC | HOLD | — | 1.0% | -1.6% | 2.7 | 3,905,743 | +0 | 5 | — |
| ☆RGNT funds › | REGENTIS BIOMATERIALS LTD | ADD | — | 0.9% | +0.6% | 2.5 | 701,685 | +450,175 | 3 | — |
| ☆PYPD funds › | POLYPID LTD | TRIM | — | 0.7% | -0.3% | 2.0 | 389,455 | -208,471 | 5 | — |
| ☆CUSIP:09077D209 funds › | BIOFRONTERA INC | ADD | — | 0.5% | +0.1% | 1.2 | 1,275,609 | +111,647 | 5 | — |
| ☆KURA funds › | KURA ONCOLOGY INC | HOLD | — | 0.4% | +0.1% | 1.1 | 100,000 | +0 | 5 | — |
| ☆SPRB funds › | SPRUCE BIOSCIENCES INC | NEW | — | 0.4% | +0.4% | 1.1 | 20,000 | +20,000 | 1 | — |
| ☆AQST funds › | AQUESTIVE THERAPEUTICS INC | HOLD | — | 0.4% | -0.0% | 1.0 | 250,000 | +0 | 2 | — |
| ☆OKUR funds › | ONKURE THERAPEUTICS INC | TRIM | — | 0.3% | -0.5% | 0.7 | 150,000 | -293,763 | 3 | — |
| ☆PEPG funds › | PEPGEN INC | NEW | — | 0.2% | +0.2% | 0.6 | 350,000 | +350,000 | 1 | — |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | EXIT | — | 0.0% | -2.0% | 0.0 | 0 | -250,401 | 0 | — |
| ☆DFTX funds › | DEFINIUM THERAPEUTICS INC | EXIT | — | 0.0% | -1.0% | 0.0 | 0 | -125,000 | 0 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | EXIT | — | 0.0% | -0.5% | 0.0 | 0 | -75,000 | 0 | — |
| ☆CUSIP:53630X203 funds › | LIPOCINE INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -221,616 | 0 | — |
| ☆CGON funds › | CG ONCOLOGY INC | EXIT | — | 0.0% | -2.8% | 0.0 | 0 | -100,000 | 0 | — |
| ☆ANNX funds › | ANNEXON INC | EXIT | — | 0.0% | -0.5% | 0.0 | 0 | -200,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 266 | 29 | 0.17 | 75% | 0.075 | 0.483 | — | in |
| 2026Q1 | 244 | 32 | 0.32 | 67% | 0.058 | 0.171 | — | in |
| 2025Q4 | 274 | 29 | 0.24 | 63% | 0.056 | 0.221 | — | in |
| 2025Q3 | 283 | 29 | 0.28 | 62% | 0.053 | 0.169 | — | in |
| 2025Q2 | 207 | 29 | 0.22 | 64% | 0.062 | 0.251 | — | entered |
| 2025Q1 | 205 | 31 | 0.00 | 63% | 0.058 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status